Slow dose escalation is the primary strategy The most effective way to minimize heart rate effects is slow, gradual dose escalation
For autoimmune patients already at risk for bone loss, this could be a clinically meaningful distinction when choosing between available GLP-1/GIP medications
The lack of substantial overlap between these two predominant clusters suggests that the WD/LD-T group has a distinct pattern of ASV relative abundances in its microbiome compared to the other treatment groups
Yamamoto H, Lee CE, Marcus JN, Williams TD, Overton JM, Lopez ME, Hollenberg AN, Baggio L, Saper CB, Drucker DJ, et al: Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons